← All Veradermics, INC filings

Veradermics, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NYSE
MANE
Veradermics, INC
SCHEDULE: Viking Global Investors Updates Stake in Veradermics
Viking Global Investors LP and associated entities filed an amendment to their Schedule 13G, reporting a 4.5% beneficial ownership stake in Veradermics, Inc. following the retirement of David C. Ott.
NYSE
MANE
Veradermics, INC
SCHEDULE: Citadel Entities Report Stake in Veradermics
Citadel entities, including Citadel Advisors LLC and Kenneth Griffin, have reported beneficial ownership of 4.5% of Veradermics, Incorporated's common stock.
NYSE
MANE
Veradermics, INC
SCHEDULE: Viking Global Discloses 5.8% Stake in Veradermics
Viking Global Investors LP and its affiliates have reported a 5.8% beneficial ownership stake in Veradermics, Inc. following the company's recent initial public offering.